Brain and Central Nervous System Tumors

Showing NaN - NaN of 58

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Brain and CNS Tumors Trial in United States (BGB 324 (before surgery), BGB 324 (after surgery))

Active, not recruiting
  • Brain and Central Nervous System Tumors
  • BGB 324 (before surgery)
  • BGB 324 (after surgery)
  • Birmingham, Alabama
  • +5 more
Dec 1, 2022

Brain and CNS Tumors, Neurotoxicity Trial in United States (temozolomide, 3-dimensional conformal radiation therapy,

Active, not recruiting
  • Brain and Central Nervous System Tumors
  • Neurotoxicity
  • Birmingham, Alabama
  • +167 more
Aug 9, 2022

Brain and CNS Tumors Trial in Worldwide (concomitant temozolomide (TMZ), radiotherapy, procarbazine)

Recruiting
  • Brain and Central Nervous System Tumors
  • concomitant temozolomide (TMZ)
  • +5 more
  • Birmingham, Alabama
  • +277 more
Mar 22, 2022

Brain and CNS Tumors, Cognitive/Functional Effects, Fatigue Trial in United States (modafinil, )

Completed
  • Brain and Central Nervous System Tumors
  • +4 more
  • Birmingham, Alabama
  • +59 more
Jul 20, 2021

Brain and CNS Tumors Trial in Canada, United States (tamoxifen citrate, radiation therapy)

Completed
  • Brain and Central Nervous System Tumors
  • tamoxifen citrate
  • radiation therapy
  • Birmingham, Alabama
  • +256 more
Oct 21, 2020

Brain and CNS Tumors Trial in Canada, United States (carmustine, radiation therapy, stereotactic radiosurgery)

Completed
  • Brain and Central Nervous System Tumors
  • Birmingham, Alabama
  • +235 more
Oct 21, 2020

Brain and CNS Tumors Trial in United States (drug, other, radiation)

Completed
  • Brain and Central Nervous System Tumors
  • Birmingham, Alabama
  • +8 more
Jun 19, 2019

Brain and CNS Tumors Trial in United States (temozolomide, 3'-deoxy-3'-[18F]fluorothymidine, pharmacological study)

Completed
  • Brain and Central Nervous System Tumors
  • Birmingham, Alabama
  • +6 more
May 21, 2019

Brain and CNS Tumors Trial in United States (terameprocol, pharmacological study)

Completed
  • Brain and Central Nervous System Tumors
  • Birmingham, Alabama
  • +8 more
Mar 1, 2019

DevelopingBlood Clot in Undergoing Cancer Treatment for Newly

Completed
  • Brain and Central Nervous System Tumors
  • Thromboembolism
  • laboratory biomarker analysis
  • +2 more
  • Birmingham, Alabama
  • +8 more
Jun 26, 2018

Brain and CNS Tumors Trial in United States (drug, genetic, other, procedure, radiation)

Completed
  • Brain and Central Nervous System Tumors
  • Birmingham, Alabama
  • +10 more
Jun 25, 2018

Brain and CNS Tumors Trial in United Kingdom (drug, genetic, other, procedure)

Completed
  • Brain and Central Nervous System Tumors
  • Bristol, England, United Kingdom
  • +6 more
Feb 1, 2018

Brain and CNS Tumors Trial in United States (iodine I 131 mAb TNT-1/B)

Completed
  • Brain and Central Nervous System Tumors
  • iodine I 131 monoclonal antibody TNT-1/B
  • Birmingham, Alabama
  • +3 more
Feb 17, 2016

Brain and CNS Tumors Trial in Canada, United States (carmustine, radiation therapy)

Completed
  • Brain and Central Nervous System Tumors
  • Birmingham, Alabama
  • +236 more
Nov 14, 2015

Brain and CNS Tumors, Neuroblastoma, Sarcoma Trial in Worldwide (vinorelbine tartrate)

Completed
  • Brain and Central Nervous System Tumors
  • +2 more
  • vinorelbine tartrate
  • Birmingham, Alabama
  • +227 more
Jul 25, 2014

Brain and CNS Tumors Trial in Worldwide (drug, procedure, radiation)

Completed
  • Brain and Central Nervous System Tumors
  • Birmingham, Alabama
  • +229 more
Feb 19, 2014

Brain and CNS Tumors, Child Solid Tumor Trial in Canada, United States (irinotecan HCl, temozolomide, vincristine sulfate)

Completed
  • Brain and Central Nervous System Tumors
  • Unspecified Childhood Solid Tumor, Protocol Specific
  • irinotecan hydrochloride
  • +2 more
  • Birmingham, Alabama
  • +17 more
Feb 18, 2014

Brain and CNS Tumors, Neurofibromatosis Type 1 Trial in Canada, United States (carboplatin, vinblastine sulfate)

Completed
  • Brain and Central Nervous System Tumors
  • Neurofibromatosis Type 1
  • Birmingham, Alabama
  • +20 more
Feb 11, 2014

Brain and CNS Tumors, Lymphoma, Lymphoproliferative Disorder Trial in Canada, United States (imetelstat sodium, laboratory

Completed
  • Brain and Central Nervous System Tumors
  • +4 more
  • imetelstat sodium
  • +2 more
  • Birmingham, Alabama
  • +22 more
Jan 29, 2014

Brain and CNS Tumors Trial in Birmingham (drug, other, radiation)

Terminated
  • Brain and Central Nervous System Tumors
  • boron phenylalanine
  • +3 more
  • Birmingham, England, United Kingdom
  • +1 more
Oct 7, 2013

Observing Young Ependymoma Undergoing Standard Combination

Active, not recruiting
  • Brain and Central Nervous System Tumors
  • +3 more
  • Birmingham, England, United Kingdom
  • +9 more
Sep 19, 2013

Brain and CNS Tumors Trial in Ireland, United Kingdom (drug, genetic, other, radiation)

Unknown status
  • Brain and Central Nervous System Tumors
  • erlotinib hydrochloride
  • +5 more
  • Dublin, Ireland
  • +20 more
Sep 19, 2013

Quality of Life in Undergone Previous Treatment for Primitive

Unknown status
  • Brain and Central Nervous System Tumors
  • +3 more
  • cognitive assessment
  • +2 more
  • Dublin, Ireland
  • +20 more
Sep 19, 2013

Brain and CNS Tumors, Chordoma, Kidney Cancer Trial in Ireland, United Kingdom (polyvinylpyrrolidone-sodium hyaluronate gel)

Unknown status
  • Brain and Central Nervous System Tumors
  • +9 more
  • polyvinylpyrrolidone-sodium hyaluronate gel
  • Dublin, Ireland
  • +20 more
Sep 19, 2013

Brain and CNS Tumors Trial in Ireland, United Kingdom (methotrexate, adjuvant therapy)

Unknown status
  • Brain and Central Nervous System Tumors
  • Dublin, Ireland
  • +20 more
Sep 16, 2013